Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis

Kathryn C. Fitzgerald, Pavan Bhargava, Matthew D. Smith, Diane Vizthum, Bobbie J. Henry-Barron, Michael D. Kornberg, Sandra D. Cassard, Dimitrios Kapogiannis, Patrick S. Sullivan, David J. Baer, Peter A. Calabresi, Ellen M. MowrymedRxiv 2022 · DOI

TL;DR

Intermittent calorie restriction (the "5:2" diet), but not daily restriction, shifts the immune profile of people with multiple sclerosis (MS) toward a less inflammatory state by reducing memory T cells and increasing naïve subsets. This immunological "reboot" appears to be driven by specific changes in lipid metabolism—specifically lysophospholipids—rather than traditional hormonal markers like leptin.

What Problem Does This Paper Address?

Multiple sclerosis is a chronic autoimmune and neurodegenerative disorder where the immune system mistakenly attacks the central nervous system. While disease-modifying therapies exist, there is intense interest in modifiable lifestyle factors, particularly diet.

Previous research in animal models (like EAE mice) showed that intermittent fasting could reduce inflammation and even promote nerve repair. However, human data has been sparse and often lacks mechanistic detail. The researchers here wanted to know: Does calorie restriction (CR) actually change the immune system in people with MS? And does the timing of that restriction (daily vs. intermittent) matter?

Methods

The authors conducted a randomized-controlled feeding study called ATAC-MS. They enrolled 36 people with relapsing-remitting MS and split them into three groups for 8 weeks:

  1. Daily CR: A steady 22% reduction in calories every day.
  2. Intermittent CR: A "5:2" style diet (75% reduction for 2 days/week; 100% for 5 days/week).
  3. Weight-Stable Control: 100% of calorie needs every day.

What makes this study robust: Unlike many "guidance-only" diet studies, the researchers provided all the food (prepared by the USDA) to ensure high adherence. They used untargeted metabolomics to track 670+ plasma metabolites and flow cytometry to precisely categorize T cell subsets (the "soldiers" of the immune system).

Datasets

The study utilized a primary clinical dataset of 36 participants with MS (81% female, average age 37.4, average BMI 32.6).

  • Metabolomics Data: Plasma samples collected at weeks 0, 4, and 8.
  • Immunological Data: Peripheral blood mononuclear cells (PBMCs) collected at weeks 0 and 8.
  • Adherence Data: 24-hour dietary recalls conducted by dieticians.

Key Insights and Ideas

  • Timing is Everything: Even though the total weekly calorie deficit was similar between the two CR groups, only the intermittent group showed significant changes in immune cell populations. This suggests that the "shock" of fasting days may be more biologically potent than a steady, mild deficit.
  • The Memory-to-Naïve Shift: Intermittent CR led to a decrease in memory T cells (which are often the "primed" cells that drive autoimmune attacks) and a proportional increase in naïve T cells. This suggests a potential "thinning out" of the pathogenic immune repertoire.
  • Lipids as Messengers: The study found that reductions in lysophospholipids and lysoplasmalogens (types of lipid metabolites) were strongly correlated with the reduction in memory T cells. This moves the conversation beyond "fat as fuel" to "fat as a signaling molecule" that dictates immune behavior.
  • The Leptin Surprise: Contrary to expectations based on other fasting studies, they did not see a significant drop in leptin or an increase in adiponectin due to CR. This suggests the observed immune changes might be independent of these common metabolic hormones.

Key Results

  • Immune Changes (Intermittent CR only):
    • Significant reductions in $CD4+_{CM}$ (-4.87%) and $CD4+_{EM}$ (-3.82%) memory cells.
  • Significant increase in $CD8+_{Naïve}$ cells (+10.11%).
  • Reduction in pro-inflammatory Th1 cells (-4.26%).
  • Metabolic Changes: Both CR diets showed a massive increase in acyl carnitine metabolism (Normalized Enrichment Score > 2.0), indicating a shift toward using fatty acids for energy.
  • Correlation: Within-person reductions in lysophospholipids were significantly associated with the reduction of memory T cell subsets (FDR-adjusted p < 0.05).

Limitations and Future Work

The authors acknowledge several hurdles:

  • Sample Size: With only 36 participants, the study is relatively small, which may explain why some trends didn't reach statistical significance.
  • Duration: Eight weeks is a snapshot in a disease that lasts decades. It is unclear if these immune shifts persist or lead to fewer clinical relapses.
  • Adherence: While food was provided, the study was remote, and adherence was self-reported.
  • Future Directions: The researchers suggest larger, longer-term trials are needed to see if these biological "proximal mediators" actually translate to better clinical outcomes for MS patients, such as reduced lesion load on MRI or improved disability scores.

Summary updated

Abstract

Abstract Background: Intermittent fasting or calorie restriction (CR) diets provide anti-inflammatory and neuroprotective advantages in models of multiple sclerosis (MS); data in humans are sparse. Methods: We conducted a randomized-controlled feeding study of different CR diets in 36 people with MS over 8 weeks. Patients were randomized to receive either: a daily CR diet (22% reduction in calories, 7 days/week), an intermittent CR diet (75% reduction, 2 days/week; 100%, 5 days/week), or a weight-stable diet (100%, 7 days/week). Untargeted metabolomics was performed on plasma samples at weeks 0, 4 and 8 at Metabolon Inc (Durham, NC). Flow cytometry of cryopreserved peripheral blood mononuclear cells at weeks 0 and 8 were used to identify CD4+ and CD8+ T cell subsets including effector memory, central memory, and naïve cells. Results: 31 (86%) completed the trial. Over time, individuals randomized to intermittent CR had significant reductions in CD4+CM -4.87%; 95%CI: -8.59%, -1.15%; p=0.01), CD4+EM (-3.82%; 95%CI: -7.44, -0.21; p=0.04), and CD8+EM (-6.96%; 95%CI: -11.96, -1.97; p=0.006) with proportional increases in naïve subsets (CD4+Naïve: 5.81%; 95%CI: -0.01, 11.63%; p=0.05; CD8+Naïve: 10.11%; 95%CI: 3.30, 16.92%; p=0.006). No changes were observed for daily CR or weight-stable diets. Larger within-person changes in lysophospholipid and lysoplasmalogen metabolites in intermittent CR were associated with larger reductions in memory T cell subsets and larger increases in naïve T cell subsets. Conclusions: In people with MS, an intermittent CR diet was associated with reduction in memory T cell subsets. The observed changes may be mediated by changes in specific classes of lipid metabolites. Trial Registration: This study is registered on Clinicaltrials.gov with identifier NCT02647502 . Funding: National MS Society, NIH, Johns Hopkins Catalyst Award
BibTeX
@misc{fitzgerald2022intermittent,
  author = {Kathryn C. Fitzgerald and Pavan Bhargava and Matthew D. Smith and Diane Vizthum and Bobbie J. Henry-Barron and Michael D. Kornberg and Sandra D. Cassard and Dimitrios Kapogiannis and Patrick S. Sullivan and David J. Baer and Peter A. Calabresi and Ellen M. Mowry},
  title = {{Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis}},
  year = {2022},
  doi = {10.1101/2022.01.11.22269094},
  howpublished = {medRxiv},
}
Figure